ALC vs. COO, HLN, CNC, HUM, IDXX, TAK, GEHC, IQV, MRNA, and RMD
Should you be buying Alcon stock or one of its competitors? The main competitors of Alcon include Cooper Companies (COO), Haleon (HLN), Centene (CNC), Humana (HUM), IDEXX Laboratories (IDXX), Takeda Pharmaceutical (TAK), GE HealthCare Technologies (GEHC), IQVIA (IQV), Moderna (MRNA), and ResMed (RMD). These companies are all part of the "medical" sector.
Cooper Companies (NASDAQ:COO) and Alcon (NYSE:ALC) are both large-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, valuation, community ranking, media sentiment, analyst recommendations, profitability, institutional ownership and risk.
Cooper Companies received 435 more outperform votes than Alcon when rated by MarketBeat users. Likewise, 66.67% of users gave Cooper Companies an outperform vote while only 60.92% of users gave Alcon an outperform vote.
24.4% of Cooper Companies shares are held by institutional investors. Comparatively, 53.9% of Alcon shares are held by institutional investors. 2.0% of Cooper Companies shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
In the previous week, Alcon had 8 more articles in the media than Cooper Companies. MarketBeat recorded 13 mentions for Alcon and 5 mentions for Cooper Companies. Cooper Companies' average media sentiment score of 0.26 beat Alcon's score of -0.11 indicating that Alcon is being referred to more favorably in the news media.
Cooper Companies currently has a consensus target price of $109.48, indicating a potential upside of 19.01%. Alcon has a consensus target price of $91.22, indicating a potential upside of 13.53%. Given Alcon's stronger consensus rating and higher possible upside, analysts clearly believe Cooper Companies is more favorable than Alcon.
Alcon has higher revenue and earnings than Cooper Companies. Alcon is trading at a lower price-to-earnings ratio than Cooper Companies, indicating that it is currently the more affordable of the two stocks.
Cooper Companies has a beta of 0.97, indicating that its stock price is 3% less volatile than the S&P 500. Comparatively, Alcon has a beta of 0.92, indicating that its stock price is 8% less volatile than the S&P 500.
Alcon has a net margin of 10.30% compared to Alcon's net margin of 7.93%. Alcon's return on equity of 8.79% beat Cooper Companies' return on equity.
Summary
Cooper Companies beats Alcon on 10 of the 18 factors compared between the two stocks.
Get Alcon News Delivered to You Automatically
Sign up to receive the latest news and ratings for ALC and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding ALC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
